20250824-华鑫证券-指数基金投资+_A股ETF转为净买入_推荐关注创新药ETF_34页_5mb

报告摘要

Core Topics and Recommendations

Market Trend: A-share ETFs have shifted to net buying, suggesting positive momentum in the A-stock market. Recommendations highlight paying close attention to innovative drug ETFs, as indicated in the report.

Key ETF Strategies and Performance

XInxuan ETF Absolute Return Strategy: Achieved 46.92% total return from 2024 start, with a Sharpe ratio of 1.56 and 6.3% maximum drawdown. Key holdings include food beverage, semiconductor, and car ETFs.
All-Round Multi-Asset Risk Parity Strategy: Showed 21.83% annual returns with a low maximum drawdown of 3.62%, utilizing a mix of global ETFs and bonds.
US-China Core Assets Combo: Delivered 68.79% returns, incorporating U.S. tech, Chinese白酒, and gold ETFs, with trend-based strategies like RSRS applied.
High Growth/Dividend Rotation Strategy: Garnered 81.59% returns by switching between high-growth and dividend-focused ETFs, e.g.,创业板ETF and红利 low-wave ETFs.

ETF New Issuances and Capital Flows

New Fund Activity: This week, 38 funds were newly established, raising 167.53 billion yuan in total, with 26 being ETFs.
Capital Flows: A-share ETFs experienced a net outflow of 140 billion yuan, but跨境ETFs saw a strong net inflow of 197.5 billion yuan, likely driven by Hong Kong market interest.

Market Performance Recap

Global Assets: Global markets were volatile, with strong performance in U.S. and Asia indices, as detailed in the report's data visualizations.
A-Share Sectors: Primary gains were in non-bank financials and basic chemicals, while technology ETFs faced losses. Hong Kong ETFs were particularly favored.

Disclaimer